[SRNE] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 131.98%
YoY- 1,630.67%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 5,778 4,105 121,910 2,243 1,103 1,276 84 102.35%
PBT -74,002 -50,380 94,953 14,031 33,244 -7,605 -3,356 67.41%
Tax -221 -826 57,480 -195 35,323 2 2 -
NP -64,415 -47,328 33,959 14,373 -939 -7,605 -3,356 63.59%
Tax Rate - - -60.54% 1.39% -106.25% - - -
Total Cost 70,193 51,433 87,951 -12,130 2,042 8,881 3,440 65.26%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -1,114.83 -1,152.94 27.86 640.79 -85.13 -596.00 -4,005.73 -19.19%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.49 -0.40 0.44 0.22 -0.03 -0.27 -0.24 12.62%
EPS Diluted -0.46 -0.40 0.44 0.22 -0.03 -0.27 -0.24 11.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.